<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Polycystic Kidney Disease - Disorder Mechanisms</title>
    <style>
        :root {
            --primary: #0f766e;
            --primary-light: #14b8a6;
            --primary-dark: #0d5c56;
            --secondary: #6366f1;
            --bg: #f0fdfa;
            --card-bg: #ffffff;
            --text: #134e4a;
            --text-muted: #5f7a78;
            --border: #ccfbf1;
            --accent-orange: #f59e0b;
            --accent-rose: #f43f5e;
            --accent-violet: #8b5cf6;
            --accent-sky: #0ea5e9;
            --banner-bg: #fef3c7;
            --banner-border: #f59e0b;
            --banner-text: #92400e;
        }

        * { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Segoe UI', system-ui, -apple-system, sans-serif;
            background: var(--bg);
            color: var(--text);
            line-height: 1.7;
        }

        .notice-banner {
            background: var(--banner-bg);
            color: var(--banner-text);
            border-bottom: 1px solid var(--banner-border);
            padding: 12px 16px;
            text-align: center;
            font-size: 0.95rem;
            cursor: pointer;
        }

        .container {
            max-width: 1100px;
            margin: 0 auto;
            padding: 24px;
        }

        /* Header */
        .page-header {
            background: linear-gradient(135deg, var(--primary) 0%, var(--primary-dark) 100%);
            color: white;
            padding: 40px 32px;
            border-radius: 16px;
            margin-bottom: 24px;
            position: relative;
            overflow: hidden;
        }

        .page-header::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -20%;
            width: 400px;
            height: 400px;
            background: rgba(255,255,255,0.05);
            border-radius: 50%;
        }

        .page-header h1 {
            font-size: 2.2rem;
            font-weight: 700;
            margin-bottom: 12px;
            position: relative;
        }

        .header-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 12px;
            align-items: center;
            position: relative;
        }

        .badge {
            display: inline-flex;
            align-items: center;
            padding: 6px 14px;
            border-radius: 20px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .badge-category {
            background: rgba(255,255,255,0.2);
            color: white;
        }

        .badge-mondo {
            background: var(--accent-sky);
            color: white;
        }

        .badge-mondo a {
            color: inherit;
            text-decoration: none;
        }

        .badge-mondo a:hover {
            text-decoration: underline;
        }

        /* Navigation */
        .breadcrumb {
            margin-bottom: 16px;
            font-size: 0.9rem;
        }

        .breadcrumb a {
            color: var(--primary);
            text-decoration: none;
        }

        .breadcrumb a:hover {
            text-decoration: underline;
        }

        .breadcrumb span {
            color: var(--text-muted);
        }

        /* Cards */
        .card {
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            padding: 24px;
            margin-bottom: 20px;
            box-shadow: 0 1px 3px rgba(0,0,0,0.04);
        }

        .card-header {
            display: flex;
            align-items: center;
            gap: 12px;
            margin-bottom: 16px;
            padding-bottom: 12px;
            border-bottom: 2px solid var(--border);
        }

        .card-icon {
            width: 36px;
            height: 36px;
            border-radius: 8px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 1.2rem;
        }

        .card-title {
            font-size: 1.1rem;
            font-weight: 600;
            color: var(--text);
        }

        .card-count {
            margin-left: auto;
            background: var(--bg);
            padding: 4px 12px;
            border-radius: 12px;
            font-size: 0.8rem;
            color: var(--text-muted);
        }

        /* Sections */
        .section-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(320px, 1fr));
            gap: 20px;
        }

        /* Tags */
        .tag-list {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
        }

        .tag {
            padding: 6px 12px;
            border-radius: 6px;
            font-size: 0.85rem;
            font-weight: 500;
        }

        .tag-cell {
            background: #fce7f3;
            color: #9d174d;
        }

        .tag-gene {
            background: #dbeafe;
            color: #1e40af;
        }

        .tag-treatment {
            background: #ede9fe;
            color: #5b21b6;
        }

        .tag-env {
            background: #ccfbf1;
            color: #0f766e;
        }

        .tag-location {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-component {
            background: #f0fdf4;
            color: #166534;
        }

        .tag-complex {
            background: #faf5ff;
            color: #7e22ce;
        }

        .tag-bio {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-modifier {
            background: #fee2e2;
            color: #991b1b;
            text-transform: uppercase;
            letter-spacing: 0.02em;
        }

        .tag-parent {
            background: #e0e7ff;
            color: #3730a3;
        }

        .tag-classification {
            background: #fef3c7;
            color: #92400e;
        }

        .tag-mechanistic {
            background: #dbeafe;
            color: #1e40af;
        }

        .linkout {
            color: inherit;
            margin-left: 6px;
            font-size: 0.75rem;
            text-decoration: none;
            border-bottom: 1px dotted rgba(0, 0, 0, 0.2);
        }

        .classification-category {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .mapping-section {
            margin-bottom: 16px;
        }

        .mapping-item {
            padding: 10px 12px;
            border: 1px solid #e2e8f0;
            border-radius: 8px;
            background: #ffffff;
            margin-bottom: 10px;
        }

        .mapping-title {
            font-size: 0.9rem;
            font-weight: 600;
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            align-items: baseline;
            margin-bottom: 6px;
        }

        .mapping-label {
            color: var(--text-muted);
            font-weight: 500;
        }

        .mapping-notes {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
        }

        .mapping-tree {
            margin-top: 6px;
            font-size: 0.75rem;
            color: var(--text-muted);
            list-style: none;
            padding-left: 0;
        }

        .mapping-tree li {
            margin: 2px 0;
        }

        /* Evidence styling */
        .evidence-toggle {
            cursor: pointer;
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 10px;
            user-select: none;
        }

        .evidence-toggle:hover {
            color: var(--primary);
        }

        .evidence-list {
            margin-top: 10px;
            padding-left: 0;
        }

        .evidence-item {
            padding: 12px 14px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .evidence-header {
            display: flex;
            align-items: center;
            flex-wrap: wrap;
            gap: 8px;
        }

        .evidence-ref {
            font-weight: 600;
            color: var(--secondary);
        }

        .evidence-ref a {
            color: inherit;
            text-decoration: none;
        }

        .evidence-ref a:hover {
            text-decoration: underline;
        }

        .evidence-support {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .support-SUPPORT { background: #dcfce7; color: #166534; }
        .support-PARTIAL { background: #fef3c7; color: #92400e; }
        .support-REFUTE { background: #fee2e2; color: #991b1b; }
        .support-NO_EVIDENCE { background: #f1f5f9; color: #64748b; }
        .support-WRONG_STATEMENT { background: #fecaca; color: #7f1d1d; }

        .evidence-source {
            font-size: 0.7rem;
            padding: 2px 8px;
            border-radius: 4px;
            font-weight: 600;
            text-transform: uppercase;
            background: #e2e8f0;
            color: #334155;
            transition: transform 120ms ease, box-shadow 120ms ease;
        }

        .evidence-support:hover,
        .evidence-source:hover {
            transform: translateY(-1px);
            box-shadow: 0 4px 10px rgba(0,0,0,0.08);
        }

        .source-HUMAN_CLINICAL { background: #e0f2fe; color: #075985; }
        .source-MODEL_ORGANISM { background: #fef9c3; color: #854d0e; }
        .source-IN_VITRO { background: #ede9fe; color: #5b21b6; }
        .source-COMPUTATIONAL { background: #cffafe; color: #0e7490; }
        .source-OTHER { background: #e5e7eb; color: #374151; }

        .evidence-snippet {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 8px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        .evidence-explanation {
            font-size: 0.85rem;
            color: var(--text);
            margin-top: 6px;
            line-height: 1.5;
        }

        .evidence-more {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-top: 6px;
            font-style: italic;
        }

        .findings-section {
            margin-top: 12px;
        }

        .findings-title {
            font-size: 0.75rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: var(--text-muted);
            margin-bottom: 6px;
        }

        .finding-item {
            padding: 10px 12px;
            background: #f8fafc;
            border-radius: 8px;
            margin-bottom: 8px;
            border: 1px solid #e2e8f0;
            font-size: 0.9rem;
        }

        .finding-statement {
            font-weight: 600;
            color: var(--text);
            margin-bottom: 6px;
            line-height: 1.5;
        }

        .finding-supporting {
            font-size: 0.85rem;
            color: var(--text-muted);
            margin-top: 6px;
            padding-left: 12px;
            border-left: 2px solid #cbd5e1;
            font-style: italic;
            line-height: 1.5;
        }

        /* Item containers with evidence */
        .item-box {
            padding: 16px;
            border-radius: 10px;
            margin-bottom: 12px;
        }

        .item-name {
            font-weight: 600;
            margin-bottom: 6px;
        }

        .item-desc {
            font-size: 0.9rem;
            line-height: 1.6;
            margin-bottom: 8px;
        }

        .item-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            margin-top: 8px;
        }

        /* Definitions */
        .definition-box {
            background: #ecfeff;
            border-left: 4px solid #0ea5e9;
        }
        .definition-box .item-name { color: #0c4a6e; }
        .definition-box .item-desc { color: #075985; }

        /* Inheritance */
        .inheritance-box {
            background: #fef9c3;
            border-left: 4px solid #ca8a04;
        }
        .inheritance-box .item-name { color: #92400e; }
        .inheritance-box .item-desc { color: #92400e; }

        .criteria-block {
            margin-top: 12px;
            padding: 12px;
            border-radius: 8px;
            border: 1px solid #bae6fd;
            background: rgba(255, 255, 255, 0.7);
        }

        .criteria-title {
            font-weight: 600;
            color: #0c4a6e;
            margin-bottom: 6px;
        }

        .criteria-meta {
            font-size: 0.8rem;
            color: var(--text-muted);
            margin-bottom: 8px;
        }

        .criteria-header {
            font-size: 0.75rem;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #0284c7;
            margin-top: 8px;
        }

        .criteria-list {
            margin-left: 18px;
            font-size: 0.9rem;
            line-height: 1.5;
            color: #0f172a;
        }

        .criteria-list li {
            margin-bottom: 6px;
        }

        .criteria-detail {
            display: block;
            font-size: 0.85rem;
            color: var(--text-muted);
        }

        /* Pathophysiology */
        .pathophys-box {
            background: linear-gradient(135deg, #fef3c7 0%, #fef9c3 100%);
            border-left: 4px solid var(--accent-orange);
        }
        .pathophys-box .item-name { color: #92400e; }
        .pathophys-box .item-desc { color: #78350f; }

        /* Histopathology */
        .histopathology-box {
            background: #fff7ed;
            border-left: 4px solid #fb923c;
        }
        .histopathology-box .item-name { color: #9a3412; }
        .histopathology-box .item-desc { color: #c2410c; }

        .histopathology-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #ffedd5;
            color: #c2410c;
        }

        /* Phenotypes */
        .phenotype-box {
            background: #f0fdf4;
            border-left: 4px solid #22c55e;
        }
        .phenotype-box .item-name { color: #166534; }
        .phenotype-box .item-desc { color: #15803d; }

        .phenotype-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #dcfce7;
            color: #15803d;
        }

        .phenotype-category {
            font-size: 0.75rem;
            color: #4ade80;
        }

        .phenotype-id a {
            font-size: 0.8rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .phenotype-id a:hover {
            text-decoration: underline;
        }

        /* Phenotype TOC strip */
        .pheno-toc {
            display: flex;
            flex-wrap: wrap;
            gap: 6px;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #e2e8f0;
            margin-bottom: 4px;
        }

        .pheno-toc-pill {
            display: inline-block;
            font-size: 0.78rem;
            padding: 3px 10px;
            border-radius: 12px;
            background: #dcfce7;
            color: #166534;
            text-decoration: none;
            cursor: pointer;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toc-pill:hover {
            background: #bbf7d0;
        }

        .pheno-toc-pill .pill-count {
            font-weight: 600;
            margin-left: 2px;
        }

        .pheno-toggle-all {
            font-size: 0.78rem;
            color: #16a34a;
            cursor: pointer;
            background: none;
            border: 1px solid #bbf7d0;
            border-radius: 6px;
            padding: 3px 10px;
            margin-left: auto;
            white-space: nowrap;
            transition: background 0.15s;
        }

        .pheno-toggle-all:hover {
            background: #f0fdf4;
        }

        /* Collapsible category groups */
        .phenotype-category-group {
            margin-bottom: 2px;
        }

        .phenotype-category-group summary {
            font-size: 0.85rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            color: #16a34a;
            margin: 0;
            padding: 10px 0 6px 0;
            border-bottom: 1px solid #bbf7d0;
            cursor: pointer;
            list-style: none;
            display: flex;
            align-items: center;
            gap: 6px;
        }

        .phenotype-category-group summary::-webkit-details-marker {
            display: none;
        }

        .phenotype-category-group summary .chevron {
            display: inline-block;
            width: 16px;
            height: 16px;
            transition: transform 0.15s;
            flex-shrink: 0;
        }

        .phenotype-category-group[open] summary .chevron {
            transform: rotate(90deg);
        }

        .phenotype-category-group summary .cat-count {
            font-size: 0.75rem;
            font-weight: 400;
            color: #15803d;
            background: #dcfce7;
            padding: 1px 7px;
            border-radius: 8px;
        }

        /* Phenotype Contexts */
        .phenotype-contexts {
            margin-top: 10px;
        }

        .phenotype-contexts-toggle {
            font-size: 0.8rem;
            color: var(--text-muted);
            cursor: pointer;
            user-select: none;
        }

        .phenotype-contexts-toggle:hover {
            color: var(--primary);
        }

        .context-card {
            padding: 10px 14px;
            margin-top: 8px;
            border-radius: 8px;
            background: #ecfdf5;
            border: 1px solid #a7f3d0;
            font-size: 0.88rem;
        }

        .context-header {
            display: flex;
            flex-wrap: wrap;
            align-items: center;
            gap: 6px;
            margin-bottom: 6px;
        }

        .context-label {
            font-size: 0.72rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.04em;
            padding: 2px 8px;
            border-radius: 4px;
        }

        .context-label-genetic {
            background: #dbeafe;
            color: #1e40af;
        }

        .context-label-sex {
            background: #fce7f3;
            color: #9d174d;
        }

        .context-label-population {
            background: #fef3c7;
            color: #92400e;
        }

        .context-label-age {
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-label-subtype {
            background: #ede9fe;
            color: #5b21b6;
        }

        .context-label-frequency {
            background: #dcfce7;
            color: #166534;
        }

        .context-gene-list {
            display: flex;
            flex-wrap: wrap;
            gap: 4px;
            margin: 4px 0;
        }

        .context-gene-tag {
            font-size: 0.78rem;
            font-weight: 600;
            padding: 1px 8px;
            border-radius: 4px;
            background: #bfdbfe;
            color: #1e3a8a;
        }

        .context-detail {
            font-size: 0.84rem;
            color: #065f46;
            line-height: 1.5;
        }

        .context-detail strong {
            color: #047857;
        }

        .context-freq {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #bbf7d0;
            color: #14532d;
            font-weight: 600;
        }

        .context-onset {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #e0e7ff;
            color: #3730a3;
        }

        .context-severity {
            font-size: 0.75rem;
            padding: 2px 8px;
            border-radius: 10px;
            background: #fef3c7;
            color: #92400e;
        }

        .context-notes {
            font-size: 0.84rem;
            color: #065f46;
            margin-top: 4px;
            line-height: 1.5;
        }

        /* Genetic */
        .genetic-box {
            background: #eff6ff;
            border-left: 4px solid #3b82f6;
        }
        .genetic-box .item-name { color: #1e40af; }
        .genetic-box .item-desc { color: #2563eb; }

        /* Treatment */
        .treatment-box {
            background: #faf5ff;
            border-left: 4px solid #8b5cf6;
        }
        .treatment-box .item-name { color: #5b21b6; }
        .treatment-box .item-desc { color: #7c3aed; }

        /* Environmental */
        .environmental-box {
            background: #f0fdfa;
            border-left: 4px solid #14b8a6;
        }
        .environmental-box .item-name { color: #0f766e; }
        .environmental-box .item-desc { color: #0d9488; }

        /* Biochemical */
        .biochemical-box {
            background: #fffbeb;
            border-left: 4px solid #f59e0b;
        }
        .biochemical-box .item-name { color: #92400e; }
        .biochemical-box .item-desc { color: #b45309; }

        /* Differential Diagnoses */
        .differential-box {
            background: #fef2f2;
            border-left: 4px solid #dc2626;
        }
        .differential-box .item-name { color: #7f1d1d; }
        .differential-box .item-desc { color: #b91c1c; }

        .differential-similarities {
            background: #fee2e2;
            border-left: 2px solid #dc2626;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-distinctions {
            background: #dcfce7;
            border-left: 2px solid #16a34a;
            padding: 10px 12px;
            border-radius: 6px;
            margin: 8px 0;
            font-size: 0.9rem;
        }

        .differential-similarities strong,
        .differential-distinctions strong {
            display: block;
            margin-bottom: 6px;
            font-size: 0.85rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        .differential-similarities ul,
        .differential-distinctions ul {
            margin-left: 16px;
            line-height: 1.6;
        }

        .differential-similarities li,
        .differential-distinctions li {
            margin: 4px 0;
            font-size: 0.9rem;
        }

        /* Datasets */
        .dataset-box {
            background: #f0f9ff;
            border-left: 4px solid #0284c7;
        }
        .dataset-box .item-name { color: #0c4a6e; }
        .dataset-box .item-desc { color: #0369a1; }

        .tag-dataset {
            background: #e0f2fe;
            color: #0369a1;
        }

        .tag-organism {
            background: #fae8ff;
            color: #a21caf;
        }

        .tag-datatype {
            background: #dbeafe;
            color: #1d4ed8;
        }

        /* Clinical Trials */
        .clinical-trial-box {
            background: #f5f3ff;
            border-left: 4px solid #a855f7;
        }
        .clinical-trial-box .item-name { color: #6b21a8; }
        .clinical-trial-box .item-desc { color: #7e22ce; }

        .tag-phase {
            background: #ede9fe;
            color: #6b21a8;
        }

        .tag-status {
            background: #fce7f3;
            color: #9d174d;
        }

        .trial-nct a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .trial-nct a:hover {
            text-decoration: underline;
        }

        .dataset-accession a {
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            color: var(--secondary);
            text-decoration: none;
        }

        .dataset-accession a:hover {
            text-decoration: underline;
        }

        /* Subtypes */
        .subtype-box {
            background: #eef2ff;
            border-left: 4px solid var(--secondary);
        }
        .subtype-box .item-name { color: #3730a3; }
        .subtype-box .item-desc { color: #4f46e5; }
        .classification-header {
            font-size: 1rem;
            font-weight: 600;
            color: #4338ca;
            margin: 1.2rem 0 0.5rem 0;
            padding-bottom: 0.3rem;
            border-bottom: 2px solid #c7d2fe;
            text-transform: capitalize;
        }
        .subtype-meta {
            display: flex;
            flex-wrap: wrap;
            gap: 0.4rem;
            margin: 0.3rem 0;
        }
        .subtype-freq-badge {
            background: #dbeafe;
            color: #1e40af;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-gene-tag {
            background: #fef3c7;
            color: #92400e;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-inheritance-tag {
            background: #ede9fe;
            color: #5b21b6;
            padding: 0.15rem 0.5rem;
            border-radius: 9999px;
            font-size: 0.8rem;
            font-weight: 500;
        }
        .subtype-term-link {
            font-size: 0.8rem;
            color: #6366f1;
            text-decoration: none;
        }
        .subtype-term-link:hover { text-decoration: underline; }
        .subtype-children {
            margin: 0.4rem 0 0.2rem 1rem;
            padding: 0;
            list-style: none;
        }
        .subtype-children li {
            font-size: 0.85rem;
            color: #4338ca;
            padding: 0.1rem 0;
        }
        .subtype-children li::before {
            content: "↳ ";
            color: #a5b4fc;
        }

        /* Stats bar */
        .stats-bar {
            display: flex;
            gap: 24px;
            padding: 20px 24px;
            background: var(--card-bg);
            border-radius: 12px;
            border: 1px solid var(--border);
            margin-bottom: 24px;
            flex-wrap: wrap;
        }

        .stat-item {
            text-align: center;
        }

        .stat-link {
            text-decoration: none;
            color: inherit;
        }

        .stat-value {
            font-size: 1.5rem;
            font-weight: 700;
            color: var(--primary);
        }

        .stat-label {
            font-size: 0.8rem;
            color: var(--text-muted);
            text-transform: uppercase;
            letter-spacing: 0.05em;
        }

        /* YAML preview */
        .yaml-preview {
            background: #1e293b;
            color: #e2e8f0;
            padding: 20px;
            border-radius: 8px;
            overflow-x: auto;
            font-family: 'Fira Code', 'Consolas', monospace;
            font-size: 0.85rem;
            line-height: 1.5;
            max-height: 400px;
            overflow-y: auto;
        }

        .yaml-content {
            display: none;
        }

        .yaml-content.show {
            display: block;
        }

        /* Footer */
        .page-footer {
            margin-top: 40px;
            padding-top: 20px;
            border-top: 1px solid var(--border);
            text-align: center;
            color: var(--text-muted);
            font-size: 0.85rem;
        }

        .page-footer a {
            color: var(--primary);
            text-decoration: none;
        }

        .page-footer a:hover {
            text-decoration: underline;
        }

        /* Responsive */
        @media (max-width: 768px) {
            .page-header h1 { font-size: 1.6rem; }
            .stats-bar { gap: 16px; }
            .section-grid { grid-template-columns: 1fr; }
        }
        /* Mermaid graph */
        .mermaid-container {
            text-align: center;
            margin: 20px 0;
            padding: 20px;
            background: white;
            border-radius: 8px;
            border: 1px solid var(--border);
            overflow-x: auto;
        }

        .mermaid svg {
            max-width: 100%;
            height: auto;
        }

        .graph-warning {
            background: #fef3c7;
            border: 1px solid #f59e0b;
            border-radius: 8px;
            padding: 12px 16px;
            margin-bottom: 16px;
            font-size: 0.85rem;
            color: #92400e;
        }

        .graph-warning strong {
            display: block;
            margin-bottom: 4px;
        }

        .graph-warning ul {
            margin: 8px 0 0 20px;
            padding: 0;
        }

        .graph-warning li {
            margin: 4px 0;
        }
    </style>
    <script src="https://cdn.jsdelivr.net/npm/mermaid@10/dist/mermaid.min.js"></script>
    <script>
        mermaid.initialize({
            startOnLoad: true,
            theme: 'default',
            flowchart: {
                htmlLabels: true,
                curve: 'basis'
            }
        });
    </script>
</head>
<body>
    <div class="notice-banner" role="button" tabindex="0">This resource is in its pre-alpha development stage. Content is actively being curated and may be incomplete or subject to change.</div>
    

    

    
    

    
    

    

    

    

    

    

    <div class="container">
        <nav class="breadcrumb">
            <a href="../../app/index.html">Browse All</a>
            <span> / </span>
            <span>Polycystic Kidney Disease</span>
        </nav>

        <header class="page-header">
            <h1>Polycystic Kidney Disease</h1>
            <div class="header-meta">
                
                <span class="badge badge-category">Mendelian</span>
                
                
                <span class="badge badge-mondo">
                    <a href="http://purl.obolibrary.org/obo/MONDO_0020642" target="_blank">
                        MONDO:0020642
                    </a>
                </span>
                
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Genetic Kidney Disease</span>
                
                <span class="badge badge-category" style="background: rgba(255,255,255,0.1);">Ciliopathy</span>
                
            </div>
            
            <p style="margin-top: 16px; font-size: 1rem; line-height: 1.6; opacity: 0.95; position: relative;">
                Polycystic kidney disease (PKD) is a genetic disorder characterized by the development of multiple fluid-filled cysts in the kidneys. The autosomal dominant form (ADPKD) is one of the most common inherited kidney diseases, affecting approximately 1 in 500-1000 people. ADPKD is caused by mutations in PKD1 or PKD2 genes and typically presents in adulthood with progressive renal enlargement, hypertension, and eventual kidney failure. Autosomal recessive PKD (ARPKD) is less common and typically presents in infancy or childhood.

            </p>
            
        </header>

        <!-- Stats bar -->
        
        
        
        
        
        
        
        
        
        
        
        
        
        <div class="stats-bar">
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Mappings</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Definitions</div>
            </div>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Inheritance</div>
            </div>
            
            
            <a class="stat-link" href="#pathophysiology">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Pathophysiology</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Histopathology</div>
            </div>
            
            
            <a class="stat-link" href="#phenotypes">
            <div class="stat-item">
                <div class="stat-value">6</div>
                <div class="stat-label">Phenotypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#genetic">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Genes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#treatments">
            <div class="stat-item">
                <div class="stat-value">4</div>
                <div class="stat-label">Treatments</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#subtypes">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Subtypes</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#differentials">
            <div class="stat-item">
                <div class="stat-value">3</div>
                <div class="stat-label">Differentials</div>
            </div>
            </a>
            
            
            <a class="stat-link" href="#datasets">
            <div class="stat-item">
                <div class="stat-value">2</div>
                <div class="stat-label">Datasets</div>
            </div>
            </a>
            
            
            <div class="stat-item">
                <div class="stat-value">0</div>
                <div class="stat-label">Trials</div>
            </div>
            
        </div>

        <!-- Classifications -->
        

        <!-- Mappings -->
        

        <!-- Definitions -->
        

        <!-- Inheritance -->
        

        <!-- Subtypes -->
        
        <div class="card" id="subtypes">
            <div class="card-header">
                <div class="card-icon" style="background: #eef2ff; color: #4f46e5;">◆</div>
                <h2 class="card-title">Subtypes</h2>
                <span class="card-count">2</span>
            </div>
            
            
            
                
                
                    
                
                
            
                
                
                
            
            
                
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Autosomal Dominant PKD (ADPKD)
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Most common form, caused by PKD1 or PKD2 mutations, typically presenting in adulthood.</div>
                    
                    
                    
    
    
                </div>
                
                <div class="item-box subtype-box">
                    <div class="item-name">
                        Autosomal Recessive PKD (ARPKD)
                        
                    </div>
                    <div class="subtype-meta">
                        
                        
                        
                    </div>
                    
                    <div class="item-desc">Less common form caused by PKHD1 mutations, presenting in infancy or childhood with more severe phenotype.</div>
                    
                    
                    
    
    
                </div>
                
            
        </div>
        

        <!-- Comorbidities -->
        

        <!-- Pathophysiology -->
        
        <div class="card" id="pathophysiology">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">⚙</div>
                <h2 class="card-title">Pathophysiology</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Vasopressin/cAMP-Driven Cyst Expansion</div>
                
                <div class="item-desc">Elevated vasopressin signaling via V2 receptors increases cAMP in tubular epithelial cells, driving chloride and fluid secretion into cysts and promoting cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        nephron tubule epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000494" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cAMP/PKA signal transduction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0141156" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"</div>
                
                
                <div class="evidence-explanation">Tolvaptan’s effect on kidney volume underscores vasopressin/cAMP signaling as a key driver of cyst expansion.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Epithelial Proliferation and Kidney Enlargement</div>
                
                <div class="item-desc">Reduced polycystin-mediated restraint on epithelial proliferation leads to progressive cyst wall growth and parenchymal compression, increasing total kidney volume and reducing renal function.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        nephron tubule epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000494" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        regulation of cell proliferation
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0042127" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"slowed the growth in total kidney volume and the decline in the estimated glomerular filtration rate"</div>
                
                
                <div class="evidence-explanation">Dampening kidney volume growth parallels slower GFR loss, linking cyst epithelial proliferation to functional decline.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Ciliary Dysfunction</div>
                
                <div class="item-desc">Primary cilia act as mechanosensors in renal tubular epithelial cells. Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular architecture and promoting cyst formation through increased cAMP signaling.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        nephron tubule epithelial cell
                        
                        <a href="http://purl.obolibrary.org/obo/CL_1000494" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        cilium organization
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0044782" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                    <span class="tag tag-bio">
                        cAMP/PKA signal transduction
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0141156" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"</div>
                
                
                <div class="evidence-explanation">Reduction of cyst growth via V2 receptor blockade underscores cAMP-mediated ciliary signaling as a driver of cystogenesis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box pathophys-box">
                <div class="item-name">Fibrosis and Inflammation</div>
                
                <div class="item-desc">Progressive cyst growth triggers interstitial inflammation and fibrosis. Activated myofibroblasts deposit extracellular matrix, contributing to nephron loss and declining kidney function.
</div>
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-cell">
                        macrophage
                        
                        <a href="http://purl.obolibrary.org/obo/CL_0000235" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
                <div class="item-meta">
                    
                    <span class="tag tag-bio">
                        inflammatory response
                        
                        <a href="http://purl.obolibrary.org/obo/GO_0006954" target="_blank" class="linkout">link</a>
                        
                    </span>
                    
    
    
                    
                </div>
                
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ADPKD accounts for 5% to 10% of kidney failure in the US and Europe"</div>
                
                
                <div class="evidence-explanation">High kidney failure burden reflects cumulative nephron loss from cyst-driven injury and interstitial fibrosis.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Histopathology -->
        

        <!-- Causal Graph -->
        

        <!-- Phenotypes -->
        
        <div class="card" id="phenotypes">
            <div class="card-header">
                <div class="card-icon" style="background: #dcfce7; color: #16a34a;">●</div>
                <h2 class="card-title">Phenotypes</h2>
                <span class="card-count">6</span>
            </div>
            
            
            <div class="pheno-toc">
                
                <a class="pheno-toc-pill" data-target="pheno-cat-1">Cardiovascular<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-2">Digestive<span class="pill-count">(1)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-3">Genitourinary<span class="pill-count">(2)</span></a>
                
                <a class="pheno-toc-pill" data-target="pheno-cat-4">Constitutional<span class="pill-count">(1)</span></a>
                
                <button class="pheno-toggle-all" id="phenoToggleAll">Expand all</button>
            </div>
            
            
            <details class="phenotype-category-group" id="pheno-cat-1">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Cardiovascular
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hypertension
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0000822" target="_blank">
                                Hypertension
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0000822)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (3 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Hypertension affects 70% to 80% of patients with ADPKD"</div>
                
                
                <div class="evidence-explanation">JAMA review confirms very high prevalence of hypertension in ADPKD patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Optimal management of ADPKD includes systolic blood pressure lower than 120 mm Hg for most patients"</div>
                
                
                <div class="evidence-explanation">Tight blood pressure targets underscore hypertension as a central clinical issue in ADPKD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40371605" target="_blank">PMID:40371605</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Comorbidities include hypertension, flank pain, and bacterial infections."</div>
                
                
                <div class="evidence-explanation">Proteomic study lists hypertension as a common comorbidity in ADPKD cohorts.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Intracranial Aneurysm
                        
                        <span class="phenotype-freq">OCCASIONAL</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0007029" target="_blank">
                                Cerebral berry aneurysm
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0007029)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"approximately 9% to 14% develop intracranial aneurysms"</div>
                
                
                <div class="evidence-explanation">JAMA review confirms intracranial aneurysms occur in 9-14% of ADPKD patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-2">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Digestive
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Hepatic Cysts
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0001407" target="_blank">
                                Hepatic cysts
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0001407)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"More than 90% of patients older than 35 years have hepatic cysts"</div>
                
                
                <div class="evidence-explanation">JAMA review confirms hepatic cysts as a very common manifestation in ADPKD.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"More than 90% of patients older than 35 years have hepatic cysts, which may cause abdominal discomfort and occasionally require medical or surgical intervention"</div>
                
                
                <div class="evidence-explanation">Describes prevalence plus symptomatic burden and intervention needs from hepatic cysts in ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-3">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Genitourinary
                    <span class="cat-count">2</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Multiple Renal Cysts
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0005562" target="_blank">
                                Multiple renal cysts
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0005562)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"</div>
                
                
                <div class="evidence-explanation">REPRISE trial confirms PKD as a cystic kidney disease defined by progressive kidney volume increase.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts"</div>
                
                
                <div class="evidence-explanation">JAMA review describes ADPKD as a progressive cystic kidney disease.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Chronic Kidney Disease
                        
                        <span class="phenotype-freq">VERY_FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0012622" target="_blank">
                                Chronic kidney disease
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0012622)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2"</div>
                
                
                <div class="evidence-explanation">Trial demonstrates progressive GFR decline in PKD patients.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age"</div>
                
                
                <div class="evidence-explanation">High rate of kidney replacement therapy highlights progression to advanced CKD in ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <details class="phenotype-category-group" id="pheno-cat-4">
                <summary>
                    <svg class="chevron" viewBox="0 0 16 16" fill="currentColor"><path d="M6 3l5 5-5 5V3z"/></svg>
                    Constitutional
                    <span class="cat-count">1</span>
                </summary>
                
                <div class="item-box phenotype-box">
                    <div class="item-name">
                        Flank Pain
                        
                        <span class="phenotype-freq">FREQUENT</span>
                        
                        
                        <span class="phenotype-id">
                            <a href="http://purl.obolibrary.org/obo/HP_0030157" target="_blank">
                                Flank pain
                            </a>
                            <span style="font-size: 0.72rem; color: var(--text-muted);">(HP:0030157)</span>
                        </span>
                        
                    </div>
                    
                    
                    
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40371605" target="_blank">PMID:40371605</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Comorbidities include hypertension, flank pain, and bacterial infections."</div>
                
                
                <div class="evidence-explanation">Proteomic study notes flank pain as a common comorbidity in ADPKD patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
                    
    
    
                </div>
                
            </details>
            
            <script>
            (function() {
                // TOC pill click: expand target group and scroll to it
                document.querySelectorAll('.pheno-toc-pill').forEach(function(pill) {
                    pill.addEventListener('click', function() {
                        var target = document.getElementById(pill.dataset.target);
                        if (target) {
                            target.open = true;
                            target.scrollIntoView({behavior: 'smooth', block: 'start'});
                        }
                    });
                });
                // Expand/collapse all toggle
                var btn = document.getElementById('phenoToggleAll');
                if (btn) {
                    btn.addEventListener('click', function() {
                        var groups = document.querySelectorAll('.phenotype-category-group');
                        var anyOpen = Array.from(groups).some(function(g) { return g.open; });
                        groups.forEach(function(g) { g.open = !anyOpen; });
                        btn.textContent = anyOpen ? 'Expand all' : 'Collapse all';
                    });
                }
            })();
            </script>
            
        </div>
        

        <!-- Genetic Associations -->
        
        <div class="card" id="genetic">
            <div class="card-header">
                <div class="card-icon" style="background: #dbeafe; color: #2563eb;">🧬</div>
                <h2 class="card-title">Genetic Associations</h2>
                <span class="card-count">3</span>
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PKD1 Mutations
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes."</div>
                
                
                <div class="evidence-explanation">JAMA review quantifies PKD1 as the predominant cause of ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PKD2 Mutations
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes."</div>
                
                
                <div class="evidence-explanation">JAMA review documents PKD2 as a minority but established cause of ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box genetic-box">
                <div class="item-name">
                    PKHD1 Mutations
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Causative)</span>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/41467628" target="_blank">PMID:41467628</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder mainly caused by mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene."</div>
                
                
                <div class="evidence-explanation">Clin Nephrol study states PKHD1 mutations as the primary cause of ARPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Treatments -->
        
        <div class="card" id="treatments">
            <div class="card-header">
                <div class="card-icon" style="background: #ede9fe; color: #7c3aed;">💊</div>
                <h2 class="card-title">Treatments</h2>
                <span class="card-count">4</span>
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Tolvaptan
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Vasopressin V2 receptor antagonist that slows cyst growth and kidney enlargement in ADPKD. First disease-modifying therapy approved for ADPKD. Requires hepatic monitoring due to risk of elevated liver enzymes.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Tolvaptan resulted in a slower decline than placebo in the estimated GFR over a 1-year period in patients with later-stage ADPKD."</div>
                
                
                <div class="evidence-explanation">REPRISE trial demonstrated tolvaptan efficacy in slowing GFR decline in PKD patients.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Blood Pressure Control
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000058" target="_blank">
                            MAXO:0000058
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Aggressive hypertension management with ACE inhibitors or ARBs to slow disease progression and reduce cardiovascular risk.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"First-line treatment includes blood pressure control, dietary and weight management, and adequate hydration."</div>
                
                
                <div class="evidence-explanation">JAMA review confirms blood pressure control as first-line treatment for ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Renal Dialysis
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0000601" target="_blank">
                            MAXO:0000601
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Dialysis (hemodialysis or peritoneal dialysis) for end-stage renal disease. PKD is one of the leading causes of kidney failure requiring dialysis.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age."</div>
                
                
                <div class="evidence-explanation">JAMA review confirms high rate of kidney replacement therapy (dialysis/transplant) in ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box treatment-box">
                <div class="item-name">
                    Kidney Transplantation
                    
                    <span class="phenotype-id">
                        <a href="https://bioregistry.io/MAXO:0010039" target="_blank">
                            MAXO:0010039
                        </a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Kidney transplantation is the preferred treatment for end-stage renal disease in PKD. Native nephrectomy may be required if kidneys are too large.
</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age."</div>
                
                
                <div class="evidence-explanation">JAMA review confirms high rate of kidney replacement therapy (dialysis/transplant) in ADPKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Environmental Factors -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #ccfbf1; color: #0d9488;">🌍</div>
                <h2 class="card-title">Environmental Factors</h2>
                <span class="card-count">1</span>
            </div>
            
            <div class="item-box environmental-box">
                <div class="item-name">Caffeine Consumption</div>
                
                <div class="item-desc">May accelerate cyst growth through increased cAMP levels; patients often advised to limit intake</div>
                
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/20301424" target="_blank">PMID:20301424</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Agents/circumstances to avoid: ... high levels of caffeine"</div>
                
                
                <div class="evidence-explanation">GeneReviews lists high caffeine intake as an avoidable factor in ADPKD management.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Biochemical Markers -->
        
        <div class="card">
            <div class="card-header">
                <div class="card-icon" style="background: #fef3c7; color: #d97706;">🔬</div>
                <h2 class="card-title">Biochemical Markers</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Elevated Creatinine
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Elevated)</span>
                    
                </div>
                
                <div class="item-desc">Context: Marker of declining renal function in advanced disease</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2"</div>
                
                
                <div class="evidence-explanation">Progressive GFR decline reflects rising creatinine as renal function deteriorates.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box biochemical-box">
                <div class="item-name">
                    Decreased GFR
                    
                    <span style="font-size: 0.8rem; font-weight: normal; opacity: 0.8;">(Decreased)</span>
                    
                </div>
                
                <div class="item-desc">Context: Progressive decline reflecting nephron loss</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"as compared with -3.61 ml per minute per 1.73 m2 (95% CI, -4.08 to -3.14) in the placebo group"</div>
                
                
                <div class="evidence-explanation">Trial quantifies ongoing GFR loss in ADPKD absent disease-modifying therapy.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Differential Diagnoses -->
        
        <div class="card" id="differentials">
            <div class="card-header">
                <div class="card-icon" style="background: #fef2f2; color: #dc2626;">🔀</div>
                <h2 class="card-title">Differential Diagnoses</h2>
                <span class="card-count">3</span>
            </div>
            <p style="margin-bottom: 16px; font-size: 0.95rem; color: var(--text-muted);">
                Conditions with similar clinical presentations that must be differentiated from Polycystic Kidney Disease:
            </p>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Simple Renal Cysts (Age-Related)
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0004840" target="_blank">
                            MONDO:0004840
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Solitary or few benign cysts that enlarge slowly with age and lack family history or extrarenal cysts. ADPKD shows bilateral numerous cysts with progressive total kidney volume growth.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Typically solitary or few cysts without kidney enlargement</li>
                        
                        <li>No hepatic cysts or family history of cystic disease</li>
                        
                        <li>Stable kidney function and volume over time</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/29105594" target="_blank">PMID:29105594</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume"</div>
                
                
                <div class="evidence-explanation">Progressive total kidney volume growth distinguishes ADPKD from stable simple cysts.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Acquired Cystic Kidney Disease (ACKD)
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0002473" target="_blank">
                            MONDO:0002473
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Cystic change that develops in chronically dialyzed kidneys, usually in the setting of long-standing kidney failure. Kidneys are often small or normal size rather than massively enlarged as in ADPKD.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Occurs after years of dialysis or advanced CKD without family history</li>
                        
                        <li>Kidneys remain small/normal sized rather than enlarged</li>
                        
                        <li>Lacks extensive hepatic cysts common in ADPKD</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Patients with MIC 1C to MIC 1E have larger kidneys because of more rapid growth (6%-10% per year)"</div>
                
                
                <div class="evidence-explanation">Rapid kidney enlargement in ADPKD contrasts with small kidneys seen in ACKD.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box differential-box">
                <div class="item-name">
                    Tuberous Sclerosis Complex (TSC)
                    
                    <span class="phenotype-id">
                        <a href="http://purl.obolibrary.org/obo/MONDO_0001734" target="_blank">
                            MONDO:0001734
                        </a>
                    </span>
                    
                </div>
                
                <div class="differential-similarities">
                    <strong>Overlapping Features</strong>
                    Genetic disorder with renal cysts and angiomyolipomas that can mimic ADPKD but accompanied by dermatologic and neurologic manifestations.

                </div>
                
                
                <div class="differential-distinctions">
                    <strong>Distinguishing Features</strong>
                    
                    <ul>
                        
                        <li>Renal angiomyolipomas and cortical tubers with seizures or developmental issues</li>
                        
                        <li>Cutaneous findings (facial angiofibromas, hypomelanotic macules) absent in ADPKD</li>
                        
                        <li>ADPKD frequently shows extensive hepatic cysts, which are uncommon in TSC</li>
                        
                    </ul>
                    
                </div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/40126492" target="_blank">PMID:40126492</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"More than 90% of patients older than 35 years have hepatic cysts"</div>
                
                
                <div class="evidence-explanation">High hepatic cyst burden supports ADPKD over TSC when liver cysts dominate.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Datasets -->
        
        <div class="card" id="datasets">
            <div class="card-header">
                <div class="card-icon" style="background: #e0f2fe; color: #0284c7;">📊</div>
                <h2 class="card-title">Related Datasets</h2>
                <span class="card-count">2</span>
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    Expression data from renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients
                    
                    <span class="dataset-accession">
                        <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7869" target="_blank">geo:GSE7869</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Microarray profiling comparing ADPKD kidney cyst epithelium with non-cystic kidney tissue to identify dysregulated pathways in cyst growth.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">MICROARRAY</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        kidney epithelium
                        
                    </span>
                    
                </div>
                
                
                <div class="item-meta" style="margin-top: 6px;">
                    <strong style="font-size: 0.8rem; color: #0369a1;">Conditions:</strong>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">ADPKD cyst epithelium</span>
                    
                    <span class="tag" style="background: #f0f9ff; color: #0369a1; font-size: 0.8rem;">non-cystic kidney tissue</span>
                    
                </div>
                
                
                
    
    
                
                <div style="margin-top: 8px; font-size: 0.85rem;">
                    <a href="http://www.ncbi.nlm.nih.gov/pubmed/19346236" target="_blank" style="color: var(--secondary);">PMID:19346236</a>
                </div>
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Public ADPKD microarray dataset frequently used to study cystogenesis-related signaling changes.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (2 references)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/23524344" target="_blank">PMID:23524344</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"Microarray data are available at GEO website (accession number: GSE7869)."</div>
                
                
                <div class="evidence-explanation">Confirms the GEO accession for the ADPKD cyst epithelium microarray dataset.</div>
                
            </div>
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/19346236" target="_blank">PMID:19346236</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"To elucidate the molecular pathways that modulate renal cyst growth in ADPKD, we performed global gene profiling on cysts of different size (&lt;1 ml, n = 5; 10-20 ml, n = 5; &gt;50 ml, n = 3) and minimally cystic tissue (MCT, n = 5) from five PKD1 human polycystic kidneys using Affymetrix HG-U133..."</div>
                
                
                <div class="evidence-explanation">Describes the PKD1 cyst epithelium microarray experiment underlying GSE7869.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
            <div class="item-box dataset-box">
                <div class="item-name">
                    GTEx v8 kidney cortex bulk RNA-seq
                    
                    <span class="dataset-accession">
                        <a href="https://gtexportal.org/home/datasets/GTEx_v8_Kidney_Cortex" target="_blank">gtex:GTEx_v8_Kidney_Cortex</a>
                    </span>
                    
                </div>
                
                <div class="item-desc">Bulk RNA-seq from healthy kidney cortex samples providing control transcriptomes for comparison to ADPKD cystic tissue.</div>
                
                <div class="item-meta">
                    
                    <span class="tag tag-organism">human</span>
                    
                    
                    <span class="tag tag-datatype">BULK RNA SEQ</span>
                    
                    
                    
                </div>
                
                <div class="item-meta" style="margin-top: 6px;">
                    
                    <span class="tag tag-cell">
                        kidney cortex
                        
                    </span>
                    
                </div>
                
                
                
                
    
    
                
                <div style="margin-top: 8px; font-size: 0.85rem;">
                    <a href="http://www.ncbi.nlm.nih.gov/pubmed/39815096" target="_blank" style="color: var(--secondary);">PMID:39815096</a>
                </div>
                
                
                <div class="item-desc" style="margin-top: 8px; font-style: italic;">Healthy kidney reference transcriptomes useful as baseline controls for differential expression analyses in ADPKD studies.</div>
                
                
    
    <details class="evidence-details">
        <summary class="evidence-toggle">
            Show evidence (1 reference)
        </summary>
        <div class="evidence-list">
            
            <div class="evidence-item">
                <div class="evidence-header">
                    <span class="evidence-ref">
                        <a href="http://www.ncbi.nlm.nih.gov/pubmed/39815096" target="_blank">PMID:39815096</a>
                    </span>
                    
                    <span class="evidence-support support-SUPPORT">SUPPORT</span>
                    
                    
                </div>
                
                <div class="evidence-snippet">"The data will comprise whole-genome sequencing, extensive bulk, single-cell and spatial gene expression profiles, and chromatin accessibility data across tissues and development."</div>
                
                
                <div class="evidence-explanation">Establishes dGTEx as a bulk expression resource providing control transcriptomes across tissues including kidney.</div>
                
            </div>
            
            
        </div>
    </details>
    
    
            </div>
            
        </div>
        

        <!-- Clinical Trials -->
        

        <!-- YAML Source -->
        <div class="card">
            <div class="card-header" style="cursor: pointer;" onclick="toggleYaml()">
                <div class="card-icon" style="background: #f1f5f9; color: #475569;">{ }</div>
                <h2 class="card-title">Source YAML</h2>
                <span class="card-count" id="yamlToggleText">click to show</span>
            </div>
            <div class="yaml-content" id="yamlContent">
                <pre class="yaml-preview">name: Polycystic Kidney Disease
category: Mendelian
description: &gt;
  Polycystic kidney disease (PKD) is a genetic disorder characterized by the
  development of multiple fluid-filled cysts in the kidneys. The autosomal dominant
  form (ADPKD) is one of the most common inherited kidney diseases, affecting
  approximately 1 in 500-1000 people. ADPKD is caused by mutations in PKD1 or PKD2
  genes and typically presents in adulthood with progressive renal enlargement,
  hypertension, and eventual kidney failure. Autosomal recessive PKD (ARPKD) is
  less common and typically presents in infancy or childhood.
disease_term:
  preferred_term: polycystic kidney disease
  term:
    id: MONDO:0020642
    label: polycystic kidney disease
parents:
  - Genetic Kidney Disease
  - Ciliopathy
has_subtypes:
  - name: Autosomal Dominant PKD (ADPKD)
    description: Most common form, caused by PKD1 or PKD2 mutations, typically presenting in adulthood.
  - name: Autosomal Recessive PKD (ARPKD)
    description: Less common form caused by PKHD1 mutations, presenting in infancy or childhood with more severe phenotype.
pathophysiology:
  - name: Vasopressin/cAMP-Driven Cyst Expansion
    description: &gt;
      Elevated vasopressin signaling via V2 receptors increases cAMP in tubular
      epithelial cells, driving chloride and fluid secretion into cysts and promoting
      cyst wall growth. Blocking V2 signaling slows total kidney volume expansion.
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume&#34;
        explanation: Tolvaptan’s effect on kidney volume underscores vasopressin/cAMP signaling as a key driver of cyst expansion.
    cell_types:
      - preferred_term: nephron tubule epithelial cell
        term:
          id: CL:1000494
          label: nephron tubule epithelial cell
    biological_processes:
      - preferred_term: cAMP/PKA signal transduction
        term:
          id: GO:0141156
          label: cAMP/PKA signal transduction
  - name: Epithelial Proliferation and Kidney Enlargement
    description: &gt;
      Reduced polycystin-mediated restraint on epithelial proliferation leads to
      progressive cyst wall growth and parenchymal compression, increasing total
      kidney volume and reducing renal function.
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;slowed the growth in total kidney volume and the decline in the estimated glomerular filtration rate&#34;
        explanation: Dampening kidney volume growth parallels slower GFR loss, linking cyst epithelial proliferation to functional decline.
    cell_types:
      - preferred_term: nephron tubule epithelial cell
        term:
          id: CL:1000494
          label: nephron tubule epithelial cell
    biological_processes:
      - preferred_term: regulation of cell proliferation
        term:
          id: GO:0042127
          label: regulation of cell proliferation
  - name: Ciliary Dysfunction
    description: &gt;
      Primary cilia act as mechanosensors in renal tubular epithelial cells.
      Polycystin dysfunction impairs ciliary signaling, disrupting normal tubular
      architecture and promoting cyst formation through increased cAMP signaling.
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume&#34;
        explanation: Reduction of cyst growth via V2 receptor blockade underscores cAMP-mediated ciliary signaling as a driver of cystogenesis.
    cell_types:
      - preferred_term: nephron tubule epithelial cell
        term:
          id: CL:1000494
          label: nephron tubule epithelial cell
    biological_processes:
      - preferred_term: cilium organization
        term:
          id: GO:0044782
          label: cilium organization
      - preferred_term: cAMP/PKA signal transduction
        term:
          id: GO:0141156
          label: cAMP/PKA signal transduction
  - name: Fibrosis and Inflammation
    description: &gt;
      Progressive cyst growth triggers interstitial inflammation and fibrosis.
      Activated myofibroblasts deposit extracellular matrix, contributing to
      nephron loss and declining kidney function.
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;ADPKD accounts for 5% to 10% of kidney failure in the US and Europe&#34;
        explanation: High kidney failure burden reflects cumulative nephron loss from cyst-driven injury and interstitial fibrosis.
    cell_types:
      - preferred_term: macrophage
        term:
          id: CL:0000235
          label: macrophage
    biological_processes:
      - preferred_term: inflammatory response
        term:
          id: GO:0006954
          label: inflammatory response
phenotypes:
  - name: Multiple Renal Cysts
    category: Renal
    frequency: VERY_FREQUENT
    description: Multiple fluid-filled cysts in both kidneys, progressively enlarging over time.
    phenotype_term:
      preferred_term: Multiple renal cysts
      term:
        id: HP:0005562
        label: Multiple renal cysts
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume&#34;
        explanation: REPRISE trial confirms PKD as a cystic kidney disease defined by progressive kidney volume increase.
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive development of kidney cysts&#34;
        explanation: JAMA review describes ADPKD as a progressive cystic kidney disease.
  - name: Hypertension
    category: Cardiovascular
    frequency: VERY_FREQUENT
    description: High blood pressure, often preceding decline in renal function.
    phenotype_term:
      preferred_term: Hypertension
      term:
        id: HP:0000822
        label: Hypertension
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Hypertension affects 70% to 80% of patients with ADPKD&#34;
        explanation: &#34;JAMA review confirms very high prevalence of hypertension in ADPKD patients.&#34;
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Optimal management of ADPKD includes systolic blood pressure lower than 120 mm Hg for most patients&#34;
        explanation: Tight blood pressure targets underscore hypertension as a central clinical issue in ADPKD.
      - reference: PMID:40371605
        supports: SUPPORT
        snippet: &#34;Comorbidities include hypertension, flank pain, and bacterial infections.&#34;
        explanation: Proteomic study lists hypertension as a common comorbidity in ADPKD cohorts.
  - name: Chronic Kidney Disease
    category: Renal
    frequency: VERY_FREQUENT
    description: Progressive decline in kidney function, with approximately 50% reaching end-stage renal disease by age 60.
    phenotype_term:
      preferred_term: Chronic kidney disease
      term:
        id: HP:0012622
        label: Chronic kidney disease
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2&#34;
        explanation: Trial demonstrates progressive GFR decline in PKD patients.
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age&#34;
        explanation: High rate of kidney replacement therapy highlights progression to advanced CKD in ADPKD.
  - name: Hepatic Cysts
    category: Hepatic
    frequency: FREQUENT
    description: Liver cysts are common extrarenal manifestation, more prevalent in women.
    phenotype_term:
      preferred_term: Hepatic cysts
      term:
        id: HP:0001407
        label: Hepatic cysts
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;More than 90% of patients older than 35 years have hepatic cysts&#34;
        explanation: &#34;JAMA review confirms hepatic cysts as a very common manifestation in ADPKD.&#34;
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;More than 90% of patients older than 35 years have hepatic cysts, which may cause abdominal discomfort and occasionally require medical or surgical intervention&#34;
        explanation: Describes prevalence plus symptomatic burden and intervention needs from hepatic cysts in ADPKD.
  - name: Intracranial Aneurysm
    category: Vascular
    frequency: OCCASIONAL
    description: Cerebral berry aneurysms occur in 5-10% of ADPKD patients, with risk of rupture.
    phenotype_term:
      preferred_term: Cerebral berry aneurysm
      term:
        id: HP:0007029
        label: Cerebral berry aneurysm
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;approximately 9% to 14% develop intracranial aneurysms&#34;
        explanation: &#34;JAMA review confirms intracranial aneurysms occur in 9-14% of ADPKD patients.&#34;
  - name: Flank Pain
    category: Renal
    frequency: FREQUENT
    description: Chronic or acute pain due to cyst hemorrhage, infection, or mass effect.
    phenotype_term:
      preferred_term: Flank pain
      term:
        id: HP:0030157
        label: Flank pain
    evidence:
      - reference: PMID:40371605
        supports: SUPPORT
        snippet: &#34;Comorbidities include hypertension, flank pain, and bacterial infections.&#34;
        explanation: Proteomic study notes flank pain as a common comorbidity in ADPKD patients.
biochemical:
  - name: Elevated Creatinine
    presence: Elevated
    context: Marker of declining renal function in advanced disease
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;The change from baseline in the estimated GFR was -2.34 ml per minute per 1.73 m2&#34;
        explanation: Progressive GFR decline reflects rising creatinine as renal function deteriorates.
  - name: Decreased GFR
    presence: Decreased
    context: Progressive decline reflecting nephron loss
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;as compared with -3.61 ml per minute per 1.73 m2 (95% CI, -4.08 to -3.14) in the placebo group&#34;
        explanation: Trial quantifies ongoing GFR loss in ADPKD absent disease-modifying therapy.
genetic:
  - name: PKD1 Mutations
    association: Causative
    notes: Accounts for approximately 85% of ADPKD cases; encodes polycystin-1; typically more severe phenotype with earlier onset of ESRD
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes.&#34;
        explanation: JAMA review quantifies PKD1 as the predominant cause of ADPKD.
  - name: PKD2 Mutations
    association: Causative
    notes: Accounts for approximately 15% of ADPKD cases; encodes polycystin-2; milder phenotype with later onset of ESRD
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;ADPKD is typically diagnosed in individuals aged 27 to 42 years and is primarily caused by pathogenic variants in the PKD1 (78%) or PKD2 (15%) genes.&#34;
        explanation: JAMA review documents PKD2 as a minority but established cause of ADPKD.
  - name: PKHD1 Mutations
    association: Causative
    notes: Causes autosomal recessive PKD; encodes fibrocystin/polyductin
    evidence:
      - reference: PMID:41467628
        supports: SUPPORT
        snippet: &#34;Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder mainly caused by mutations in the polycystic kidney and hepatic disease 1 (PKHD1) gene.&#34;
        explanation: Clin Nephrol study states PKHD1 mutations as the primary cause of ARPKD.
environmental:
  - name: Caffeine Consumption
    notes: May accelerate cyst growth through increased cAMP levels; patients often advised to limit intake
    evidence:
      - reference: PMID:20301424
        supports: SUPPORT
        snippet: &#34;Agents/circumstances to avoid: ... high levels of caffeine&#34;
        explanation: GeneReviews lists high caffeine intake as an avoidable factor in ADPKD management.
treatments:
  - name: Tolvaptan
    description: &gt;
      Vasopressin V2 receptor antagonist that slows cyst growth and kidney
      enlargement in ADPKD. First disease-modifying therapy approved for ADPKD.
      Requires hepatic monitoring due to risk of elevated liver enzymes.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;Tolvaptan resulted in a slower decline than placebo in the estimated GFR over a 1-year period in patients with later-stage ADPKD.&#34;
        explanation: REPRISE trial demonstrated tolvaptan efficacy in slowing GFR decline in PKD patients.
  - name: Blood Pressure Control
    description: &gt;
      Aggressive hypertension management with ACE inhibitors or ARBs to slow
      disease progression and reduce cardiovascular risk.
    treatment_term:
      preferred_term: pharmacotherapy
      term:
        id: MAXO:0000058
        label: pharmacotherapy
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;First-line treatment includes blood pressure control, dietary and weight management, and adequate hydration.&#34;
        explanation: &#34;JAMA review confirms blood pressure control as first-line treatment for ADPKD.&#34;
  - name: Renal Dialysis
    description: &gt;
      Dialysis (hemodialysis or peritoneal dialysis) for end-stage renal disease.
      PKD is one of the leading causes of kidney failure requiring dialysis.
    treatment_term:
      preferred_term: renal dialysis
      term:
        id: MAXO:0000601
        label: renal dialysis
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age.&#34;
        explanation: &#34;JAMA review confirms high rate of kidney replacement therapy (dialysis/transplant) in ADPKD.&#34;
  - name: Kidney Transplantation
    description: &gt;
      Kidney transplantation is the preferred treatment for end-stage renal disease
      in PKD. Native nephrectomy may be required if kidneys are too large.
    treatment_term:
      preferred_term: organ transplantation
      term:
        id: MAXO:0010039
        label: organ transplantation
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Approximately 50% of individuals with ADPKD require kidney replacement therapy by 62 years of age.&#34;
        explanation: &#34;JAMA review confirms high rate of kidney replacement therapy (dialysis/transplant) in ADPKD.&#34;
differential_diagnoses:
  - name: Simple Renal Cysts (Age-Related)
    disease_term:
      preferred_term: simple renal cyst
      term:
        id: MONDO:0004840
        label: non-congenital cyst of kidney
    description: &gt;
      Solitary or few benign cysts that enlarge slowly with age and lack family history
      or extrarenal cysts. ADPKD shows bilateral numerous cysts with progressive total
      kidney volume growth.
    distinguishing_features:
      - Typically solitary or few cysts without kidney enlargement
      - No hepatic cysts or family history of cystic disease
      - Stable kidney function and volume over time
    evidence:
      - reference: PMID:29105594
        supports: SUPPORT
        snippet: &#34;the vasopressin V2-receptor antagonist tolvaptan slowed the growth in total kidney volume&#34;
        explanation: Progressive total kidney volume growth distinguishes ADPKD from stable simple cysts.
  - name: Acquired Cystic Kidney Disease (ACKD)
    disease_term:
      preferred_term: acquired cystic kidney disease
      term:
        id: MONDO:0002473
        label: cystic kidney disease
    description: &gt;
      Cystic change that develops in chronically dialyzed kidneys, usually in the
      setting of long-standing kidney failure. Kidneys are often small or normal size
      rather than massively enlarged as in ADPKD.
    distinguishing_features:
      - Occurs after years of dialysis or advanced CKD without family history
      - Kidneys remain small/normal sized rather than enlarged
      - Lacks extensive hepatic cysts common in ADPKD
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;Patients with MIC 1C to MIC 1E have larger kidneys because of more rapid growth (6%-10% per year)&#34;
        explanation: Rapid kidney enlargement in ADPKD contrasts with small kidneys seen in ACKD.
  - name: Tuberous Sclerosis Complex (TSC)
    disease_term:
      preferred_term: tuberous sclerosis
      term:
        id: MONDO:0001734
        label: tuberous sclerosis
    description: &gt;
      Genetic disorder with renal cysts and angiomyolipomas that can mimic ADPKD but
      accompanied by dermatologic and neurologic manifestations.
    distinguishing_features:
      - Renal angiomyolipomas and cortical tubers with seizures or developmental issues
      - Cutaneous findings (facial angiofibromas, hypomelanotic macules) absent in ADPKD
      - ADPKD frequently shows extensive hepatic cysts, which are uncommon in TSC
    evidence:
      - reference: PMID:40126492
        supports: SUPPORT
        snippet: &#34;More than 90% of patients older than 35 years have hepatic cysts&#34;
        explanation: High hepatic cyst burden supports ADPKD over TSC when liver cysts dominate.
datasets:
  - accession: geo:GSE7869
    title: Expression data from renal cysts of autosomal dominant polycystic kidney disease (ADPKD) patients
    description: Microarray profiling comparing ADPKD kidney cyst epithelium with non-cystic kidney tissue to identify dysregulated pathways in cyst growth.
    organism:
      preferred_term: human
      term:
        id: NCBITaxon:9606
        label: Homo sapiens
    data_type: MICROARRAY
    sample_types:
      - preferred_term: kidney epithelium
        tissue_term:
          preferred_term: kidney
          term:
            id: UBERON:0002113
            label: kidney
    conditions:
      - ADPKD cyst epithelium
      - non-cystic kidney tissue
    publication: PMID:19346236
    notes: &gt;-
      Public ADPKD microarray dataset frequently used to study cystogenesis-related signaling changes.
    evidence:
      - reference: PMID:23524344
        supports: SUPPORT
        snippet: &#34;Microarray data are available at GEO website (accession number: GSE7869).&#34;
        explanation: Confirms the GEO accession for the ADPKD cyst epithelium microarray dataset.
      - reference: PMID:19346236
        supports: SUPPORT
        snippet: &#34;To elucidate the molecular pathways that modulate renal cyst growth in ADPKD, we performed global gene profiling on cysts of different size (&lt;1 ml, n = 5; 10-20 ml, n = 5; &gt;50 ml, n = 3) and minimally cystic tissue (MCT, n = 5) from five PKD1 human polycystic kidneys using Affymetrix HG-U133 Plus 2.0 arrays.&#34;
        explanation: Describes the PKD1 cyst epithelium microarray experiment underlying GSE7869.

  - accession: gtex:GTEx_v8_Kidney_Cortex
    title: GTEx v8 kidney cortex bulk RNA-seq
    description: Bulk RNA-seq from healthy kidney cortex samples providing control transcriptomes for comparison to ADPKD cystic tissue.
    organism:
      preferred_term: human
      term:
        id: NCBITaxon:9606
        label: Homo sapiens
    data_type: BULK_RNA_SEQ
    sample_types:
      - preferred_term: kidney cortex
        tissue_term:
          preferred_term: kidney cortex
          term:
            id: UBERON:0001225
            label: kidney cortex
    publication: PMID:39815096
    notes: &gt;-
      Healthy kidney reference transcriptomes useful as baseline controls for differential expression analyses in ADPKD studies.
    evidence:
      - reference: PMID:39815096
        supports: SUPPORT
        snippet: &#34;The data will comprise whole-genome sequencing, extensive bulk, single-cell and spatial gene expression profiles, and chromatin accessibility data across tissues and development.&#34;
        explanation: Establishes dGTEx as a bulk expression resource providing control transcriptomes across tissues including kidney.
</pre>
            </div>
        </div>

        <footer class="page-footer">
            <p>
                Generated from <a href="https://github.com/monarch-initiative/dismech" target="_blank">dismech</a>
                knowledge base
            </p>
            <p style="margin-top: 8px;">
                <a href="https://github.com/monarch-initiative/dismech/blob/main/kb/disorders/Polycystic_Kidney_Disease.yaml" target="_blank">View source on GitHub</a>
            </p>
        </footer>
    </div>

    <script>
        function toggleYaml() {
            const content = document.getElementById('yamlContent');
            const toggleText = document.getElementById('yamlToggleText');
            content.classList.toggle('show');
            toggleText.textContent = content.classList.contains('show') ? 'click to hide' : 'click to show';
        }
    </script>
    <script>
        (function() {
            const banner = document.querySelector('.notice-banner');
            if (!banner) return;
            const dismiss = () => banner.remove();
            banner.addEventListener('click', dismiss);
            banner.addEventListener('keydown', (event) => {
                if (event.key === 'Enter' || event.key === ' ') {
                    event.preventDefault();
                    dismiss();
                }
            });
        })();
    </script>
</body>
</html>